Status:
COMPLETED
Lidocaine Versus Bupivacaine for Sphenopalatine Ganglion Block
Lead Sponsor:
Huda Fahmy Mahmoud, PhD
Conditions:
Septum; Deviation, Congenital
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The endoscopic septoplasty technique is one of the most frequently performed operations by otolaryngologists throughout the world. It is suggested that 86% of patients who undergo an endoscopic septop...
Detailed Description
Methods: Eligible patients will be evaluated by: Preoperative: Explanation of visual analog scale will be done to patients (the VAS consists of a straight, vertical 10-cm line; the bottom point rep...
Eligibility Criteria
Inclusion
- The patients planned to perform endoscopic septoplasty
- American Society of Anesthesiologists class I and II
Exclusion
- patients that will be received additional surgery with endoscopic septoplasty
- patients under the age of 18
- Patients have systemic or bleeding disorders
- patients who disincline to participate in the study
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05269147
Start Date
March 1 2022
End Date
September 1 2022
Last Update
September 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huda Fahmy
Aswān, Egypt, 81511